Citi analyst Yigal Nochomovitz reiterated a Buy rating and $88 price target on Puma Biotechnology (NASDAQ: PBYI) after 'very good ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE